Documente Academic
Documente Profesional
Documente Cultură
Roland Valori
National Clinical Director of Endoscopy England
Hypertension
Monitoring BP
Control of BP
Hypertension
Colonoscopy
Surrogate of surrogate
Monitoring BP
Withdrawal time
Surrogate
Control of BP
Adenoma detection
Direct
Missed cancer
Hypertension
Colonoscopy
Surrogate of surrogate
Monitoring BP
Withdrawal time
Easy
Surrogate
Control of BP
Adenoma detection
Moderate
Direct
Missed cancer
Hard
Hypertension
Colonoscopy
Surrogate of surrogate
Easy
Surrogate
Control of BP
Moderate
Direct
Hard
Ultimate
Cancer rates
Easy
National audit
Regional audit Rates of cancer Missed cancer ADR
National performance
Locality performance
Performance indicators
Individual performance
inputs
Withdrawal rates
Local improvement
The number of first occurrence of a patient with a primary diagnosis of colorectal cancer (C18 C21) by month English data
First occurrence of a FCE with a primary diagnosis of bowel cancer C18 C21
3500 Monthly count of FCE 5 per. Mov. Avg. (Monthly count of FCE) 3000
2500
new patients/month
2000
1500
500
0 2002
2003
2004
2005
2006
2007
2008
2009
2010
Provisional data
1000
rise in new cases over previous year 1.2% 1.2% 2.4% 2.5% 1.3% 1.3%
200
150
100
50
Would you be prepared to have a colonoscopy done by a colonoscopist from your country selected at random?
NO: because you know there is unacceptably variable performance
Performance
the best
performance
competent incompetent
time
retirement
Quality in Endoscopy: Colonoscopy, Berlin 2012
performance
competent incompetent
time
retirement
Quality in Endoscopy: Colonoscopy, Berlin 2012
Performance indicator
is a numerical measure of the consequence or impact of the competencies associated with the task
Auditable outcome
is a performance indicator which should be measured but for which there is not a defined numerical standard
performance
competent incompetent
time
retirement
Quality in Endoscopy: Colonoscopy, Berlin 2012
Therapy
completeness of removal complications
PE-W = patient experience worse than expected NRCS-45 = nurse recorded comfort score levels 4 or 5 (level 1 = comfortable; level 5 = severe discomfort)
Quality in Endoscopy: Colonoscopy, Berlin 2012
Discomfort vs CIR
Pt experience vs CIR
The experts
Midazolam (mean)
PDR (%)
93.3
10.0
5.6
2.3
29.6
93.4
94.6
7.8
7.6
4.2
4.1
2.0
1.8
27.4
31.9
2011
95.9
5.8
3.7
1.7
37.7
performance
competent incompetent
time
retirement
Quality in Endoscopy: Colonoscopy, Berlin 2012
Assessment technique
Direct Observation of Procedural Skills DOPS Performance measures and auditable outcomes
Time
Quality in Endoscopy: Colonoscopy, Berlin 2012
Polypectomy
1999
1999
Performance indicators
Intubation KPIs CIR ADR comfort use of sedation perforation non technical skills Polypectomy KPIs removal technique used judgements completeness of excision retrieval rate use of tattoo complications appropriate surveillance intervals rates of cancer in surveillance patients non technical skills
polypectomy
performance
competent incompetent
time
retirement
Quality in Endoscopy: Colonoscopy, Berlin 2012
Recognise what it is
Recognise what it is
Knowledge
Skills
Judgement Skills
Recognise what it is
Knowledge
Skills
TEAMWORK
Quality in Endoscopy: Colonoscopy, Berlin 2012
100% 80% 60% 40% 20% 0% 2007 Q3 2007 Q4 2008 Q1 2008 Q2 2008 Q3
Assessment, Consent, Communication Safety & sedation Endoscopic Skills during insertion & withdrawal Diagnostic & Therapeutic Ability
# DOPS
19
25
63
59
25
Recognise what it is
Knowledge
Skills
The best
performance
Test of competencies to jump a level, or to determine whether someone should go down a level KPIs demonstrate adequate performance at a given level
time
retirement
Accurate measurement
everyone assesses the numerator precisely
Rate of advanced adenoma and cancer at one year in high risk group in FOBT screen positives
Polyp profiles Index colonoscopy Total (%)
>3 adenomas; more than one >10mm >5 adenomas; more than one >10mm
12 month surveillance
997(56.6)
Rate of advanced adenoma and cancer at one year in high risk group in FOBT screen positives
Polyp profiles Index colonoscopy Total (%)
>3 adenomas; more than one >10mm >5 adenomas; more than one >10mm
997(56.6)
Key recommendation
9.23 The occurrence of colorectal cancer in any individual in whom adenomas or pT1 cancers have been detected at a previous exam should be captured as an auditable outcome for any surveillance programme
The standard for patients fulfilling high risk criteria, and who have had clearance of polyps, should be <1% cancer at one year
Withdrawal time
Adenoma detection Incomplete excision Complications Missed cancer
Differentiate between intubation/diagnosis and therapy Consider whether a parameter is a direct measure or surrogate Appreciate that the frequency of measure determines sample size to detect differences in performance
some events are very infrequent and can only be captured at unit, regional or national level
Quality in Endoscopy: Colonoscopy, Berlin 2012